arrow
返回
C

Christopher L. Bowlus

university of texas system

70H指数
433论文数
1.6W被引数
收录论文 214
发表时间
Response to Commentary on “Impact of Disease-Specific Treatment and NSBBs on Risk of PVT in Cirrhotic Patients With HCV or PBC”对“疾病特异性治疗和NSBBs对伴有HCV或PBC的肝硬化患者PVT风险的影响”一文的评论回复
err2026-08-13
err0
PREAI
errHumberto C. Gonzalez; Stuart C. Gordon; Sheri Trudeau; Trueman Wu; Lora Rupp; Christina Melkonian; Mark A. Schmidt; Yihe Daida; Amandeep K. Sahota; Christopher L. Bowlus; Mei Lu
err分享
err收藏
Fatigue and Cognitive Impairment in Adults With Primary Sclerosing Cholangitis: Results From Concept Elicitation Interviews原发性硬化性胆管炎患者的疲劳和认知障碍:概念引出访谈的结果
err2026-08-11
err0
errOAAI
errDonna M. Evon; Kaya Merkler; Laura Mkumba; Nicole Lucas; Lauren Wright; Joanne Hatchett; Rachel Gomel; Patrick J. Smith; Sasha Deutsch-Link; Christopher L. Bowlus; Mark G. Swain; Bryce B. Reeve
err分享
err收藏
Seladelpar in patients with primary biliary cholangitis and compensated cirrhosis: Efficacy and safety from RESPONSE and ASSURE studies塞拉德尔帕(Seladelpar)在原发性胆汁性胆管炎合并代偿期肝硬化患者中的疗效与安全性:来自RESPONSE和ASSURE研究的数据
err2026-05-01
err0
PREAI
errGordon, Stuart C.; Villamil, Alejandra; Jacobson, Ira M.; Lawitz, Eric J.; Younes, Ziad; Silveira, Marina G.; Bowlus, Christopher L.; Drenth, Joost P. H.; Vierling, John M.; Morgera, Ulrike; Vasura, Adam; Dalekos, George; Galli, Andrea; Rabinovitz, Mordechai; Heo, Jeong; Nevens, Frederik; Levy, Cynthia; Zhou, Yan; Carroll, Susheela; Crittenden, Daria B.
err分享
err收藏
Impact of Disease-Specific Treatment and Non-Selective Beta Blockers on Risk of PVT in Cirrhotic Patients With HCV or PBC疾病特异性治疗和非选择性β受体阻滞剂对HCV或PBC肝硬化患者PVT风险的影响
err2026-04-03
err0
errOAAI
errHumberto C. Gonzalez; Stuart C. Gordon; Sheri Trudeau; Trueman Wu; Lora Rupp; Christina Melkonian; Mark A. Schmidt; Yihe G. Daida; Amandeep K. Sahota; Christopher L. Bowlus; Mei Lu
err分享
err收藏
Induction of Antigen-Specific T Cell Tolerance by CNP-104 Positively Affects Clinical Response in Primary Biliary Cholangitis (PBC)
err2025-11-01
err0
PREAI
errElhofy, Adam; Bowlus, Christopher; Frey, Molly; McCarthy, Derrick P.; Wambre, Erik; Caldwell, Stephen; Firpi-Morell, Roberto; Fortune, Brett; Galambos, Michael; Gordon, Stuart; Harnois, Denise; Hassanein, Tarek; Kappus, Matthew; Lawitz, Erik; Mchenry, Scott; Patel, Bhaktasharan; Phillips, Raymond; Pratt, Daniel; Pruthi, Jatinder; Rajendiran, Govarthanan; Reddy, Gautham; Rodriguez, Manuel; Silveira, Marina; Zervos, Bobby; Peloso, Paul; Gershwin, M. Eric
err分享
err收藏
Cilofexor in non-cirrhotic primary sclerosing cholangitis (PRIMIS): a randomised, double-blind, multicentre, placebo-controlled, phase 3 trialCilofexor在非肝硬化原发性硬化性胆管炎(PRIMIS)中的应用:一项随机、双盲、多中心、安慰剂对照的III期临床试验
err2025-10-28
err0
PREAI
errMichael Trauner; Cynthia Levy; Atsushi Tanaka; Zachary Goodman; Douglas Thorburn; Deepak Joshi; Kimmo Salminen; Kidist Yimam; Hiroyuki Isayama; Aldo J Montano-Loza; Stephen Caldwell; Mark Danta; Martti Farkkila; Juan F Gallegos-Orozco; Stuart C Gordon; Holger Hinrichsen; Pietro Invernizzi; Raj Vuppalanchi; Kaiyi Zhu; Jun Xu; Xiangyu Liu; Xiaomin Lu; Gerald Crans; Shahla Bolbolan; Lisa Boyette; Muhsen Alani; William T Barchuk; Timothy R Watkins; Mark C Genovese; Christopher L Bowlus
err分享
err收藏
Linerixibat in patients with primary biliary cholangitis and cholestatic pruritus (GLISTEN): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial利尼瑞昔bat在原发性胆汁性胆管炎和胆汁淤积性瘙痒患者中的疗效(GLISTEN):一项随机、多中心、双盲、安慰剂对照的III期临床试验
err2025-10-28
err0
PREAI
errGideon M Hirschfield; Christopher L Bowlus; David E J Jones; Andreas E Kremer; Marlyn J Mayo; Atsushi Tanaka; Pietro Andreone; Jidong Jia; Qinglong Jin; Ricardo U Macías-Rodríguez; Alexander R Cobitz; Brooke M Currie; Ciara Gorey; Ivana Lazic; Danielle Podmore; Andrea Ribeiro; Jennifer B Shannon; Brandon Swift; Megan M McLaughlin; Cynthia Levy
err分享
err收藏
err分享
err收藏
Phase II INTEGRIS-PSC trial of bexotegrast, an αvβ6/αvβ1 integrin inhibitor, in primary sclerosing cholangitisII期INTEGRIS-PSC试验中,bexotegrast(一种αvβ6/αvβ1整合素抑制剂)用于原发性硬化性胆管炎的研究。
err2025-09-26
err0
PREAI
errGideon M. Hirschfield; Kris V. Kowdley; Palak J. Trivedi; Bertus Eksteen; Bilal Hameed; Catherine Vincent; Tianyan Chen; Aparna Goel; K.Gautham Reddy; Eric Orman; Deepak Joshi; Éric A. Lefebvre; Johanna R. Schaub; Mahru C. An; Annie Clark; Chris N. Barnes; Richard Pencek; Douglas Thorburn; Aldo J. Montano-Loza; Christoph Schramm; Christopher L. Bowlus; Michael Trauner; Cynthia Levy
err分享
err收藏
Recompensation in patients with autoimmune hepatitis-related decompensated cirrhosis following immunosuppressive therapy自身免疫性肝炎相关失代偿期肝硬化的患者在免疫抑制治疗后的代偿恢复
err2025-06-01
err0
errOAAI
errYu Chen; Haoyu Wen; You Li; Weituo Zhang; Tianyu Mao; Chenyi Jiang; Huayang Zhang; Yujie Zhou; Xiting Pu; Bo Li; Jun Zhang; Li Yan; Min Lian; Li Sheng; Canjie Guo; Qixia Wang; Qi Miao; Jing Hua; Hai Li; Ruqi Tang; Christopher L. Bowlus; M. Eric Gershwin; Zhengrui You; Xiao Xiao; Xiong Ma
err分享
err收藏
Safety and efficacy of elafibranor in primary sclerosing cholangitis: The ELMWOOD phase II randomized-controlled trialLevy, C.; Abouda, G.F.; Bilir, B.M.; Bonder, A.; Bowlus, C.L.; Campos-Varela, I.; Cazzagon, N.; Chandok, N.; Cheent, K.; Cortez-Pinto, H.; 等. Elafibranor在原发性硬化性胆管炎中的安全性与有效性:ELMWOOD II期随机对照试验. J. Hepatol. 2025. [Google Scholar] [CrossRef] [PubMed]
err2025-05-10
err0
errOAAI
errCynthia Levy; George F. Abouda; Bahri M. Bilir; Alan Bonder; Christopher L. Bowlus; Isabel Campos-Varela; Nora Cazzagon; Natasha Chandok; Kuldeep Cheent; Helena Cortez-Pinto; Münevver Demir; Michael T. Dill; Bertus Eksteen; Jonathan M. Fenkel; Richard Gilroy; Hin Hin Ko; Ira M. Jacobson; Yiannis Kallis; Marcelo Kugelmas; Velimir Luketic
err分享
err收藏
Development of the natural history component of an early economic model for primary sclerosing cholangitis原发性硬化性胆管炎早期经济模型的自然史成分的发展
err2025-03-18
err0
errOAAI
errBowlus, Christopher; Levy, Cynthia; Kowdley, Kris V.; Kachru, Nandita; Jeyakumar, Sushanth; Rodriguez-Guadarrama, Yael; Smith, Nathaniel; Briggs, Andrew; Sculpher, Mark; Ollendorf, Daniel
err分享
err收藏
Long-Term Efficacy and Safety of Open-Label Seladelpar Treatment in Patients With Primary Biliary Cholangitis: Pooled Interim Results for up to 3 Years From the ASSURE Study
err2025-02-01
err0
PREAI
errLawitz, E. J.; Trivedi, P. J.; Kowdley, K. V.; Gordon, S. C.; Bowlus, C. L.; Londono, M. C.; Hirschfield, G. M.; Gulamhusein, A.; Crittenden, D. B.; Frigerio, F.; Zhuo, S.; Heusner, C.; Levy, C.
err分享
err收藏
Fecal deoxycholic acid associates with diet, intestinal microbes, and total bilirubin in primary sclerosing cholangitis在原发性硬化性胆管炎中,粪便脱氧胆酸与饮食,肠道微生物和总胆红素有关
err2024-12-01
err0
errOAAI
errChan, Connie; Lemos, Mateus; Finnegan, Peter; Gagnon, William; Dean, Richard; Yazdanafar, Maryam; Zepeda, Joseph; Vohl, Marie-Claude; Trauner, Michael; Korzenik, Joshua R.; Barbier, Olivier; Marco, Maria L.; Bowlus, Christopher L.
err分享
err收藏
COBALT: A Confirmatory Trial of Obeticholic Acid in Primary Biliary Cholangitis With Placebo and External Controls (Aug, 10.14309/ajg.0000000000003029, 2024)COBALT:奥贝胆酸在原发性胆汁性胆管炎中的验证性试验(含安慰剂和外部对照)(Aug, 10.14309/ajg.0000000000003029, 2024)
err2024-11-29
err1
PREAI
errKowdley, KV; Hirschfield, GM; Coombs, C; Malecha, ES; Bessonova, L; Li, J; Rathnayaka, N; Mells, G; Jones, DE; Trivedi, PJ; Hansen, BE; Smith, R; Wason, J; Hiu, S; Kareithi, DN; Mason, AL; Bowlus, CL; Muller, K; Carbone, M; Berenguer, M; Milkiewicz, P; Adekunle, F; Villamil, A
err分享
err收藏
Primary Biliary Cholangitis: personalizing second-line therapies
err2024-11-12
err0
PREAI
errLevy, Cynthia; Bowlus, Christopher L.
err分享
err收藏
Anti-integrin αvβ6 Autoantibodies Are Increased in Primary Sclerosing Cholangitis Patients With Concomitant Inflammatory Bowel Disease and Correlate With Liver Disease Severity抗整合素αvβ6自身抗体在原发性硬化性胆管炎伴发炎症性肠病患者中升高,并与肝脏疾病严重程度相关
err2024-10-25
err0
PREAI
errHannah Bloemen; Alexandra E. Livanos; Adrielly Martins; Richard Dean; Ana Catarina Bravo; Arno R. Bourgonje; Michael Tankelevich; Jake Herb; Judy Cho; André Anastácio Santos; Cecília M.P. Rodrigues; Francesca Petralia; Jean-Frederic Colombel; Christopher L. Bowlus; Thomas Schiano; Joana Torres; Cynthia Levy; Saurabh Mehandru
err分享
err收藏
Obeticholic Acid Normalizes Inflammatory Biomarkers in Patients With Primary Biliary Cholangitis
err2024-10-01
err0
PREAI
errFoston, Tenita; Jones, David E.; Bowlus, Christopher L.; Thranian, Arash; Erickson, Mary; Li, Jing; Gasink, Christopher; Gish, Robert G.
err分享
err收藏
Long-Term Efficacy and Safety of Open-Label Seladelpar Treatment in Patients With Primary Biliary Cholangitis: Interim Results for 2 Years From the ASSURE Study开放标签下塞拉德帕治疗原发性胆汁性胆管炎的长期有效性与安全性:ASSURE研究2年期的中期结果
err2024-10-01
err0
PREAI
errTrivedi, PJ; Levy, C; Kowdley, KV; Gordon, SC; Bowlus, CL; Hurtado, MCL; Hirschfield, GM; Gulamhusien, AF; Lawitz, EJ; Villamil, A; Cetina, AD; Mayo, MJ; Younes, ZH; Shibolet, O; Yimam, KK; Pratt, DS; Heo, J; Morgera, U; Andreone, P; Kremer, AE; Corpechot, C; Goel, A; Peyton, A; Elbeshbeshy, H; Crittenden, DB; Heusner, C; Proehl, S; Zhou, SQ; Mcwherter, CA
err分享
err收藏